BSE filing, NSE: EUREKAI. Summary written from the filing by ALFA Finder's alert engine.
Eureka Industries Ltd: key numbers
- Share price
- ₹8.00
- Market cap
- ₹7.00 Cr
- Revenue (annual)
- ₹125.1 Cr
- Net profit (annual)
- ₹0.20 Cr
- P/E (TTM)
- -70.3×Sector 49.0×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eureka Industries Ltd
All →Eureka Industries Management Change
Eureka Industries disclosed the resignation of CS Priyal Patel as Company Secretary and Compliance Officer effective 07 Sept 2026. The departure was due to personal reasons and career opportunities, with no material reasons.
Eureka Industries Q1 FY27 Results: Net Loss of ₹0.2 Cr
Eureka Industries Ltd reported a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Eureka Industries Insolvency Petition
Eureka Industries announced that NCLT, Ahmedabad admitted its petition for the Pre-Packaged Insolvency Resolution Process (PPIRP), effective August 14, 2026.
Eureka Industries Board Meeting Date
Eureka Industries will hold a board meeting on August 14, 2026, to consider and approve the standalone financial results for the quarter ended June 30, 2026.
Eureka Industries Other Announcement
Eureka Industries is changing its Registrar and Share Transfer Agent to Accurate Securities and Registry Private Limited. The change aims to strengthen investor services.
Eureka Industries Other Announcement
Eureka Industries declared non-applicability of SEBI's Related Party Transaction disclosure requirements for March 2026. The exemption applies as the company's financial metrics remain below regulatory thresholds.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.